Glutathione S-transferases (GST) and efflux pumps in tumor cells can diminish the efficacy of various chemotherapeutic agents, including cyclophosphamide [58], cisplatin [59], and others [60], by reducing their intracellular reactivity and promoting drug efflux. The gene discussed is HPGDS; the disease is neoplasm.